2025 ISAKOS Biennial Congress ePoster
Almost 79% Survival Rate At 10-Year Follow-Up For The Patellofemoral Joint Arthroplasty: A Registry Study
Piero Agostinone, MD, Bologna QATAR
Anna Pagano, MD, Bologna ITALY
Domenico Alesi, MD, Bologna ITALY
Alberto Grassi, PhD, Bologna ITALY
Stefano Zaffagnini, MD, Prof., Bologna ITALY
Istituto Ortopedico Rizzoli, Bologna, ITALY
FDA Status Not Applicable
Summary
Survivorship analysis of patellofemoral joint replacement and clinical outcomes of a selected subgroup of patients
ePosters will be available shortly before Congress
Abstract
Purpose
The aims of the present study were (1) to evaluate the survival of patellofemoral joint (PFJ) arthroplasty in a large cohort of patients using data obtained from an Italian regional arthroplasty registry and (2) to collect clinical outcomes of a subgroup of patients, with a minimum follow-up of 4 years. The hypotheses were that PFJ arthroplasty is a procedure that had good survival and clinical outcomes, not inferior to those reported in the literature for primary total knee arthroplasty (TKA).
Methods
A regional registry of joint replacement database was searched to include all PFJ arthroplasties implanted between 2003 and 2019. PFJ arthroplasties were excluded if implanted in patients living outside of the Region. The survival information was extrapolated from the registry considering the partial or total revision of the implant as failure; moreover, a subgroup of patients was contacted and interviewed by telephone to collect clinical outcomes. Descriptive statistics were used to summarise the data. The survival curve was calculated and plotted using the Kaplan-Meier method.
Results
A total of 126 arthroplasties in 114 patients were included in the final analysis (mean age at surgery 60.1 ± 11.5 years old). The main causes of patellofemoral arthroplasty were primary osteoarthritis (88%) and posttraumatic arthritis (7%). The survival was 90.4 ± 30.6 and 78.8 ± 51.5 at 5 and 10 years of follow-up, respectively. At the latest follow-up, 23 implants failed (18.3%). The main cause of revision was osteoarthrosis progression (34.8%). A total of 44 patients were contacted by telephone to collect clinical outcomes: Western Ontario and McMaster Universities Osteoarthritis Index, functional Knee Society Score, Forgotten Joint Score and Oxford Knee Score. These patients reported good to excellent scores at a medium follow-up of 10.3 ± 4.7 years.
Conclusions
The PFJ showed good survival and clinical outcomes and could be considered a valuable option for patients affected by isolated patellofemoral osteoarthritis.